Skip to content
Aminoscope
Updated October 2026

Willow review

By Nadia Feldman · Aminoscope

Prices every dose

Our verdict

Willow advertises compounded semaglutide injections from $299 a month and tirzepatide injections from $399, with prices listed by dose. It names the prescribing practice and partner-pharmacy locations, while its state lists and refund cutoffs differ across pages.

Main trade-offs

  • Tirzepatide injection reaches $549 monthly at the top listed dose
  • FAQ names 37 states but older consent lists differ; patients with diabetes are excluded

Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.

Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.

Check availability →Semaglutide injection or tablet from $299/mo; tirzepatide injection $399–$549/mo by dose. FAQ lists 37 states; confirm eligibility

Good fit

Readers in a supported state who want dose-specific prices and pharmacy disclosures before deciding, and who will confirm the policy differences.

Consider other options if

Anyone with diabetes, anyone whose state or selected prescription is not supported, or buyers who need a single unambiguous refund cutoff.

Cost and care at a glance

Category
GLP-1 telehealth
Published cost
Semaglutide injection or tablet from $299/mo; tirzepatide injection $399–$549/mo by dose. FAQ lists 37 states; confirm eligibility
Medications
Compounded semaglutide · Compounded tirzepatide · Oral
Insurance
Cash-pay, no insurance
Visit
Quiz intake / Async intake
Availability
FAQ lists 37 states; confirm treatment eligibility
LegitScript
Claimed by provider

Our review in detail

Full assessment

Willow publishes a price for each listed dose: semaglutide injection starts at $299 monthly and tirzepatide at $399, with tirzepatide reaching $549. Its terms name the prescribing practice and partner-pharmacy locations, including two RedRock addresses, and disclose the chief medical officer’s equity stake. Confirm the selected prescription before enrolling: the FAQ names 37 states but older consent lists differ, patients with diabetes are excluded, and its pages describe different refund cutoffs.

What it is

An online weight-loss service operated by Willow Health Services, Inc., a Houston, Texas company, selling compounded semaglutide and tirzepatide by weekly injection or daily under-the-tongue tablet, a combination semaglutide/tirzepatide tablet, and a compounded NAD⁺ injection. The company describes itself as a technology platform rather than a medical provider: prescribing is done by physicians of an affiliated practice, which its consent form names as Willow Medical of California, P.C., and medication is dispensed by partner pharmacies. Its mission statement is written for women ("dedicated to improving women's overall wellbeing"), though nothing in the eligibility rules limits it to women. It claims more than 100,000 patients and displays a LegitScript seal (ID 2142601).

How care works

Asynchronous. You answer an online health questionnaire, upload a government-issued photo ID, and a U.S.-licensed physician reviews it, writes a treatment plan and, if you qualify, prescribes the same day. After that, you message your physician through a patient portal at no extra charge, and Willow says you will usually keep the same physician. It publishes the names of its physicians on a dedicated page. Once a prescription is written, pharmacy processing takes two to four business days and delivery another two to three by FedEx or UPS. Eligibility is stricter than many GLP-1 services: adults 18 and over who are not pregnant or breastfeeding, with no eating disorder, recent bariatric surgery, gallbladder disease, pancreatitis, or history of medullary thyroid cancer or MEN2 — and no diabetes, although pre-diabetes and high blood pressure are accepted. The terms list partner-pharmacy addresses, including RedRock locations in Springville and St. George, Utah, alongside Epiq, Absolute, The Pharmacy Hub and Empower. The site does not say which pharmacy fills which product, or whether each is a 503A or 503B facility.

Costs, billing and cancellation

The monthly subscription renews automatically and includes medication, the physician, portal messaging and shipping; Willow does not bill insurance directly and discusses HSA/FSA eligibility. Its price sheet lists semaglutide injection at $299 monthly through 3.5 mg and $399 at 7 mg. Tirzepatide injection is $399 at 2.125, 4.25 and 6.375 mg, $499 at 8.5 and 11 mg, $524 at 13.5 mg and $549 at 17 mg. Tirzepatide tablets are $399 at 6 and 10 mg and $459 at 20 mg; the combination tablet is $399 or $459. Semaglutide tablets are listed at $299 across dosages, and NAD⁺ injection at $199 monthly. These are seller-listed prices, not dosing recommendations. Using an outside pharmacy adds a platform fee and a separate medication bill; the current FAQ does not quote the fee amount. The FAQ requires cancellation at least two business days before the next processing date and offers a full refund before the prescription is sent to the pharmacy. The consent instead limits full refunds to cancellations within 24 hours of ordering. Confirm your selected price, renewal date and applicable refund rule before paying.

Medication and evidence

Compounded semaglutide and tirzepatide, by weekly injection or as a daily tablet dissolved under the tongue, plus a combination tablet containing both, and a compounded NAD⁺ injection. Willow's compounding disclosures are clear and appear on every product page, and its tablet guide adds a line many sellers leave out: "There is no FDA-approved oral-dissolving formulation of semaglutide or tirzepatide." On the evidence: the weight-loss trial data for semaglutide and tirzepatide belongs to the branded injections, and the FDA does not test compounded versions for potency or purity. The under-the-tongue tablets are a further step removed. The only approved oral semaglutide is a tablet you swallow, built around an absorption enhancer, and no approved oral tirzepatide exists, so how much of a dissolving-tablet dose reaches the bloodstream has not been shown in published human trials. Willow's statement that the tablet "bypass[es] the digestive system and liver" describes the route, not a demonstrated dose. Its tirzepatide injection ladder runs to 17 mg, above the 15 mg top dose on Zepbound's label and beyond the doses the pivotal trials tested. For NAD⁺, Willow promises "youthful energy" and "a brighter, more vibrant-looking complexion". Injected NAD⁺ has no controlled human outcome trials, and the oral precursors NR and NMN, the forms with human data, show a raised blood level rather than a clinical benefit. Individual results vary.

Pros and watch-outs

What we like

  • Publishes prices for the listed doses
  • Semaglutide injection starts at $299 monthly and tirzepatide at $399
  • Partner-pharmacy addresses and the prescribing practice are named
  • The chief medical officer’s equity stake is disclosed in writing
  • Injection and needle-free tablet options for both semaglutide and tirzepatide
  • Displays a LegitScript seal; HSA/FSA eligibility discussed

Watch-outs

  • Tirzepatide injection reaches $549 monthly at the top listed dose
  • FAQ names 37 states but older consent lists differ; patients with diabetes are excluded
  • Outside-pharmacy platform fee is not quoted in the current FAQ
  • Refund cutoffs differ between the FAQ and consent
  • Under-the-tongue GLP-1 tablets have no published human absorption data
  • NAD⁺ marketing claims outrun the evidence

Best for

Readers in a supported state who want dose-specific prices and pharmacy disclosures before deciding, and who will confirm the policy differences.

Who should look elsewhere

Anyone with diabetes, anyone whose state or selected prescription is not supported, or buyers who need a single unambiguous refund cutoff.

Research relevant to Willow

Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.

How Willow compares

A few alternatives worth a look, depending on what you’re optimizing for.

Our MEDGm review and Shed review describe what each service publishes about pricing, billing and cancellation.

  • MEDGm

    Readers who want compounded and brand-name GLP-1 routes presented side by side

    See MEDGm →
  • Shed

    A wide range of GLP-1 formats (injection, drops, lozenges, microdose)

    See Shed →
  • Mondae

    Readers comparing published one-, three- and six-month GLP-1 plan totals

    See Mondae →
Compare all providers side by side →

More GLP-1 telehealth reviews: Breeze MedsTelos RXLongevityFix MDPomegranate HealthGide HealthVevaRX

NF
Nadia Feldman

Access & cost

How we assessed this. This review is based on Willow’s own website and published terms, read for pricing transparency, clinical oversight, medication clarity and access against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

How much does Willow cost at higher doses?
Willow publishes the full ladder. Semaglutide injection is $299 a month at every dose up to 3.5 mg and $399 at 7 mg. Tirzepatide injection is $399 at the three lowest doses (2.125, 4.25 and 6.375 mg), $499 at 8.5 and 11 mg, $524 at 13.5 mg and $549 at 17 mg. Tirzepatide tablets are $399 at 6 and 10 mg and $459 at 20 mg. Each figure is a monthly subscription price with medication, the physician and shipping included.
Which states does Willow serve?
The current FAQ names 37 states: Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin and Wyoming. Older consent lists are shorter and differ. Confirm that Willow can prescribe your selected treatment where you live; the FAQ list alone does not establish individual eligibility.
Can I use Willow if I have type 2 diabetes?
No. Willow states that it cannot currently accept patients with diabetes, although pre-diabetes and high blood pressure are accepted. That rules out a large group of people for whom GLP-1 drugs are commonly prescribed, so if you have diabetes, a service that treats it, or your own doctor, is the route.
What happens if I want to cancel or get a refund?
You cancel by messaging the care team, and the subscription is not locked in. To avoid the next charge, cancel at least two business days before your next processing date. On refunds, Willow's pages differ: the FAQ and help center promise a full refund if you cancel before the prescription is sent to the pharmacy, while the refund section of its consent form limits full refunds to cancellations within 24 hours of the order. Once medication is compounded or shipped, it cannot be returned. Ask the care team in writing which rule applies before you pay.
What should I compare with Willow’s monthly price?
Compare the same medication, route, dose and billing term, including any required care fee. Willow lists semaglutide injection from $299 monthly and tirzepatide injection from $399, with some doses costing more. MEDGm’s shortest semaglutide injection plan also renews at $299 monthly after a $179 introductory month. A first-month offer or a prepaid monthly equivalent is a different charge from an ongoing monthly plan.
Can I get NAD⁺ from Willow without a GLP-1?
Standalone availability needs confirmation. Willow lists NAD⁺ injection at $199 monthly, but its public enrollment description still refers to weight-loss care. Ask whether it can be prescribed separately and whether your state is supported. On the evidence, injected NAD⁺ has no controlled human outcome trials, so treat the energy and complexion claims as marketing.
Is Willow legit?
Willow is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide, Compounded tirzepatide and an oral form. Its stated availability: FAQ lists 37 states; confirm treatment eligibility. What it publishes up front: Semaglutide injection or tablet from $299/mo; tirzepatide injection $399–$549/mo by dose. FAQ lists 37 states; confirm eligibility. It is cash-pay and states it does not bill insurance. It shows a LegitScript seal. Ask the company for its certificate number before you rely on it. Before you pay, ask in writing about your selected charge, billing interval, supply and required fees.